A
Arvinas D
D
ARVN
7.84500
USD
-0.05
(-0.63%)
مغلق
حجم التداول
43,999
الربح لكل سهم
-0
العائد الربحي
-
P/E
-12
حجم السوق
572,617,455
الأخبار المقالات
العنوان: Arvinas
القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.